Thouvenot D - Search Results

1

Resistance of herpes simplex virus type 1 to acyclovir: thymidine kinase gene mutagenesis study.

Frobert E, Ooka T, Cortay JC, Lina B, Thouvenot D, Morfin F. Frobert E, et al. Among authors: thouvenot d. Antiviral Res. 2007 Feb;73(2):147-50. doi: 10.1016/j.antiviral.2006.08.001. Epub 2006 Aug 30. Antiviral Res. 2007. PMID: 16970995

2

A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir.

Danve C, Morfin F, Thouvenot D, Aymard M. Danve C, et al. Among authors: thouvenot d. J Virol Methods. 2002 Sep;105(2):207-17. doi: 10.1016/s0166-0934(02)00103-9. J Virol Methods. 2002. PMID: 12270654

3

Herpes simplex virus resistance to antiviral drugs.

Morfin F, Thouvenot D. Morfin F, et al. Among authors: thouvenot d. J Clin Virol. 2003 Jan;26(1):29-37. doi: 10.1016/s1386-6532(02)00263-9. J Clin Virol. 2003. PMID: 12589832 Review.

4

Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses.

Frobert E, Cortay JC, Ooka T, Najioullah F, Thouvenot D, Lina B, Morfin F. Frobert E, et al. Among authors: thouvenot d. Antiviral Res. 2008 Jul;79(1):28-36. doi: 10.1016/j.antiviral.2008.01.153. Epub 2008 Feb 21. Antiviral Res. 2008. PMID: 18336925

5

Drug targets in herpes simplex and Epstein Barr Virus infections.

Billaud G, Thouvenot D, Morfin F. Billaud G, et al. Among authors: thouvenot d. Infect Disord Drug Targets. 2009 Apr;9(2):117-25. doi: 10.2174/187152609787847703. Infect Disord Drug Targets. 2009. PMID: 19275700 Review.

6

HSV excretion after bone marrow transplantation: a 4-year survey.

Morfin F, Bilger K, Boucher A, Thiebaut A, Najioullah F, Bleyzac N, Raus N, Bosshard S, Aymard M, Michallet M, Thouvenot D. Morfin F, et al. Among authors: thouvenot d. J Clin Virol. 2004 Aug;30(4):341-5. doi: 10.1016/j.jcv.2004.03.002. J Clin Virol. 2004. PMID: 15163425

7

S-adenosyl methionine decarboxylase activity is required for the outcome of herpes simplex virus type 1 infection and represents a new potential therapeutic target.

Greco A, Callé A, Morfin F, Thouvenot D, Cayre M, Kindbeiter K, Martin L, Levillain O, Diaz JJ. Greco A, et al. Among authors: thouvenot d. FASEB J. 2005 Jul;19(9):1128-30. doi: 10.1096/fj.04-2108fje. Epub 2005 Apr 28. FASEB J. 2005. PMID: 15863396

8

Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone.

Morfin F, Dupuis-Girod S, Frobert E, Mundweiler S, Carrington D, Sedlacek P, Bierings M, Cetkovsky P, Kroes AC, van Tol MJ, Thouvenot D. Morfin F, et al. Among authors: thouvenot d. Antivir Ther. 2009;14(1):55-61. Antivir Ther. 2009. PMID: 19320237

9

Detection of measles vaccine in the throat of a vaccinated child.

Morfin F, Beguin A, Lina B, Thouvenot D. Morfin F, et al. Among authors: thouvenot d. Vaccine. 2002 Feb 22;20(11-12):1541-3. doi: 10.1016/s0264-410x(01)00495-9. Vaccine. 2002. PMID: 11858860

10

In vitro susceptibility of adenovirus to antiviral drugs is species-dependent.

Morfin F, Dupuis-Girod S, Mundweiler S, Falcon D, Carrington D, Sedlacek P, Bierings M, Cetkovsky P, Kroes AC, van Tol MJ, Thouvenot D. Morfin F, et al. Among authors: thouvenot d. Antivir Ther. 2005;10(2):225-9. Antivir Ther. 2005. PMID: 15865216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters